The company will provide Sanofi with information going back to 1994.
News
The future of GP care lies with ‘micro-teams’
The current regimen has been declared “unfit for purpose” by Professor Helen Stokes-Lampard.
MSD’s Keytruda falls short in late stage breast cancer study
The blockbuster drug did not meet its pre-specified primary endpoint of superior overall survival.
AI could spot lung cancer before radiologists
The deep-learning system also produced fewer false positives and fewer false negatives.
Positive Phase I results for Allergy’s Acarovac
Good news for patients with house dust mite-induced allergic rhinoconjunctivitis.
AbbVie ends Phase III brain tumour study due to failed primary goal
Enrolment in all ongoing Depatux-M studies has been halted.
ECH makes moves toward facilitating medical cannabis importation in UK, EU
Astral Health will act as a gateway to the European cannabis market.
Categories refined for the 2019 Medical & Scientific Excellence Awards
The categories in the 2019 PharmaTimes Medical & Scientific Excellence Awards have been refined to greater reflect the latest trends within the industry.
AZ Symbicort reduces rate of asthma attacks
The results showed a a 51% reduction in the rate of annual asthma exacerbations compared to albuterol.
Owlstone Medical, Actelion team up for pulmonary hypertension detection
Currently, early diagnosis of PH is very difficult and a delay of years between the onset of symptoms and diagnosis and treatment is unfortunately common.
‘Record’ number of patients taking part in clinical trials
Over 870,250 participants were involved in NIHR supported health and social care studies over the last twelve months.
New screening to help detect Group B Strep in pregnant women
The UK is one of the only countries in the developed world where there is currently no standard screening programme for the bug.
Europeans at risk of chronic digestive diseases due to poor diets
High consumption of ultra-processed foods also increases the prevalence of obesity.
EMA’s PRAC to review Xeljanz and recommends fenspiride withdrawl
The committee has announced its latest meeting highlights.
NICE recommends Revlimid as multiple myeloma alternative
The new indication will benefit approximately 2,100 patients.
